Stocks & ETFs Screener: 94 results (Pharmaceuticals)
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | Return 12m vs S&P 500 |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
921B | 82.9% | 68.5% | 68.4% | 49.5 | 21.2% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
506B | 75.4% | 60.2% | 62.5% | 20.0 | 26.0% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
284B | 82.7% | 39.2% | 73.5% | 30.4 | 23.2% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
282B | 86.4% | 42.0% | 52.8% | 30.2 | 8.96% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
254B | 91.9% | 59.2% | 96.6% | 18.2 | 23.9% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
247B | 83.1% | 63.4% | 9.91% | 12.9 | -10.3% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
223B | 89.4% | 40.5% | -44.4% | 13.5 | -59.4% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
147B | 57.3% | 74.4% | -39.0% | 15.0 | -10.8% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
119B | 63.5% | 54.6% | 21.9% | 15.8 | -9.88% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
118B | 75.2% | 64.2% | -11.8% | 15.8 | -20.0% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
109B | 73.8% | 58.8% | -36.4% | 18.0 | -14.0% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
99.5B | 79.3% | 19.8% | 79.2% | 13.8 | 29.0% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
96.8B | 80.1% | 31.2% | 63.4% | 13.4 | 14.4% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
60.4B | 61.6% | 37.6% | -59.7% | 17.4 | -25.3% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
52.6B | 88.6% | 68.9% | -49.2% | 20.0 | -35.6% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
47.5B | 63.0% | 35.5% | 27.7% | 204 | 1.93% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
41.5B | 47.1% | 1.0% | 5.82% | - | 62.6% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
34.2B | 53.3% | 17.8% | 77.3% | 48.8 | 21.2% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
22.3B | 59.7% | 71.4% | 34.1% | 21.9 | 38.7% |
| VTRS Viatris |
Pharmaceuticals
Brand, Generic, Biosimilar |
13.5B | 28.8% | 59.1% | 9.20% | - | -12.1% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Neuroscience, Rare |
11.8B | 87.4% | 50.2% | 42.5% | 22.6 | -3.86% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.7B | 77.7% | 45.1% | 38.4% | 18.1 | -19.7% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
10.6B | 43.1% | - | 61.0% | 304 | 60.5% |
| JAZZ Jazz |
Pharmaceuticals
Xywav, Xyrem, Epidiolex, Rylaze |
10.3B | 51.2% | - | 13.3% | - | 15.7% |
| CORT Corcept |
Pharmaceuticals
Hyperglycemia, Cushings |
8.76B | 67.4% | - | 88.9% | 95.6 | 39.3% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Wake-Promoting |
7.50B | 32.3% | - | 81.8% | - | 44.7% |
| TERN Terns |
Pharmaceuticals
TKI, THR-Agonist, GLP-1-Agonist |
5.01B | 34.8% | - | 68.8% | - | 461% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
3.85B | 61.6% | - | 85.1% | - | 38.0% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.47B | 36.6% | - | 77.2% | - | 33.2% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.35B | 85.6% | 57.2% | 49.7% | 21.5 | -4.26% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
3.07B | 30.4% | - | 77.0% | - | 26.5% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
3.05B | 64.0% | 0.21% | -17.6% | 15.3 | -33.2% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
3.04B | 36.0% | - | 37.5% | - | 3.08% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
2.84B | 25.8% | - | 93.7% | - | 177% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.71B | 46.7% | - | 53.4% | - | 22.5% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.53B | 51.8% | 4.23% | -9.65% | 7.18 | -20.8% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.33B | 91.9% | - | -21.1% | 12.8 | -5.08% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.13B | 64.4% | 49.5% | -29.6% | 16.9 | -15.0% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.10B | 63.7% | - | 86.3% | - | 80.7% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.85B | 69.3% | - | 92.7% | 51.5 | 29.9% |
| MAZE Maze Therapeutics |
Pharmaceuticals
Precision Medicine, APOL1 |
1.85B | 24.4% | - | 93.0% | - | 130% |
| PRGO Perrigo |
Pharmaceuticals
OTC, Vitamins, Infant Formula |
1.84B | 48.1% | 73.9% | -79.6% | - | -53.8% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.81B | 56.8% | 51.4% | -87.1% | 3.64 | -58.7% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.69B | 37.5% | - | 92.7% | - | 167% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.9% | 2.39% | 63.6% | 13.4 | -5.14% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.66B | 44.3% | - | 79.6% | - | 14.7% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.62B | 61.5% | 34.6% | 84.6% | 23.9 | 47.7% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.53B | 80.1% | - | 82.1% | 29.7 | 36.6% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.49B | 22.2% | - | -82.0% | - | -47.1% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.41B | 27.3% | - | 77.8% | - | 108% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
1.41B | 48.4% | - | -41.8% | - | -18.2% |
| RAPP Rapport |
Pharmaceuticals
Antiepileptic, Analgesic |
1.37B | 31.7% | - | 59.0% | - | 47.0% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.30B | 30.2% | - | -4.36% | - | 158% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.19B | 76.6% | - | -19.2% | 11.3 | -42.6% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.19B | 62.9% | - | 85.7% | - | 83.1% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
1.16B | 47.9% | - | 29.7% | 27.6 | 34.7% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.15B | 46.7% | - | 60.6% | - | 7.55% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.11B | 63.1% | - | -26.4% | 52.7 | 14.6% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Treg Stimulator, PEG-CSF1, TNFR2 |
1.11B | 32.5% | - | 39.2% | - | 183% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.04B | 65.2% | - | 46.5% | - | 90.7% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
951M | 32.7% | - | -14.0% | - | -37.2% |
| ARVN Arvinas |
Pharmaceuticals
PROTAC, Cancer, Breast, Prostate |
923M | 39.5% | - | -63.8% | - | -44.3% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
905M | 92.3% | - | 63.0% | 5.20 | 15.3% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Ampreloxetine |
892M | 51.2% | - | 67.0% | 30.9 | 64.3% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
852M | 23.3% | - | 54.9% | - | 159% |
| AQST Aquestive |
Pharmaceuticals
Film-Based Drugs, Anaphylaxis |
721M | 59.2% | - | 80.3% | - | 35.6% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
707M | 16.2% | - | -77.1% | - | -53.5% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
626M | 40.7% | - | 22.9% | - | -20.2% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
595M | 33.8% | - | -10.3% | - | 226% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Liquor, Pre-Rolls |
494M | 50.7% | - | -1.56% | - | -5.58% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
459M | 28.9% | - | -31.3% | - | -44.7% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox, TPOXX, Health |
457M | 79.6% | 88.9% | 33.6% | 6.19 | -2.30% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Bipolar Depression, Major |
444M | 43.9% | - | 31.2% | - | 357% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
441M | 46.6% | - | -5.81% | 0.90 | 120% |
| ETON Eton |
Pharmaceuticals
Hormone, Enzyme, Metabolic |
428M | 56.4% | - | 74.3% | - | 13.4% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
419M | 30.5% | - | -41.0% | - | -25.2% |
| NMRA Neumora |
Pharmaceuticals
Kappa Antagonist, Agitation Drug |
353M | 49.5% | - | -57.5% | - | -85.8% |
| RLMD Relmada |
Pharmaceuticals
Controlled-Release, Formulation |
331M | 45.3% | - | 40.2% | - | 949% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
328M | 32.8% | - | -43.4% | - | -3.55% |
| ACB Aurora Cannabis |
Pharmaceuticals
Dried Cannabis, Cannabis Oil |
315M | 66.8% | - | -27.6% | - | 2.93% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Obesity |
315M | 25.5% | - | 0.72% | - | -14.5% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis,Flower,Pre-Rolls,Vapes,Edi.. |
257M | 40.4% | - | -8.55% | 192 | 17.1% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
248M | 35.4% | - | -35.4% | - | -14.7% |
| MDWD Mediwound |
Pharmaceuticals
Eschar,Burn,Therapy,Tissue,Biopharm.. |
246M | 20.2% | - | 29.6% | - | -7.15% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 27.9% | 1.0% | -39.2% | - | -67.4% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
200M | 24.4% | - | -32.1% | - | 6.66% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Disease |
147M | 39.9% | - | 6.45% | - | 72.4% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 33.9% | 0.17% | -45.5% | - | -19.2% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
139M | 45.7% | - | 14.4% | - | 33.1% |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
129M | 26.1% | - | -52.4% | - | -1.62% |
| CNTX Context |
Pharmaceuticals
Therapeutics, Oncology |
104M | 29.9% | - | 37.8% | - | -0.87% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
102M | 67.5% | - | -40.1% | - | -20.7% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual, Aspirin, Melatonin |
14.4M | 39.1% | - | -82.3% | - | -99.3% |
| KALA Kala |
Pharmaceuticals
Eye Drops, Ophthalmic Solutions |
8.26M | 25.4% | - | -74.6% | - | -91.2% |